Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01066312 · ClinicalTrials.gov registry record
The Accuracy of Manual Muscle Testing
A clinical trial of Lying, sponsored by Parker Research Institute.
- Completed
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT01066312: Completed study of Lying, sponsored by Parker Research Institute.
NCT01066312 is a study of Lying that has completed, run by Parker Research Institute. The registered enrollment target is 160 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01066312, a study of Lying, has completed, sponsored by Parker Research Institute.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Manual Muscle Testing (MMT) practiced by over a million practitioners worldwide. However, it's accuracy under varying levels of blindness has not yet been considered. This study will test this accuracy. Study Hypothesis: MMT can accurately distinguish congruent from incongruent statements. Also, the accuracy of MMT is positively correlated with practitioner experience.
Conditions Studied
Study Locations (1)
Texas
- Parker Research Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-06 |
What the finished NCT01066312 record still lists
NCT01066312 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Lying appearing as the primary indexed condition, and to 0 interventions.
NCT01066312 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01066312 about?
NCT01066312 is a clinical study titled "The Accuracy of Manual Muscle Testing". Manual Muscle Testing (MMT) practiced by over a million practitioners worldwide. However, it's accuracy under varying levels of blindness has not yet been considered. This study will test this accuracy. Study Hypothesis: MMT can accurately distinguish congruent from incongruent statements. Also, th...
What is the current status of trial NCT01066312?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2010-03. Estimated completion is 2013-06.
What conditions does trial NCT01066312 study?
This clinical trial studies the following conditions: Lying.
Who is sponsoring clinical trial NCT01066312?
This trial is sponsored by Parker Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01066312 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia